KAVITA PRABHAKAR SARFARE

      DIN: 01843634

      For latest information about the director, visit MCA.

      KAVITA PRABHAKAR SARFARE is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 01843634. KAVITA PRABHAKAR SARFARE is/has been associated with 18 companies.

      This is just one Director. Want to discover lot more?

      Unlock deeper insights with Prime Research AI

      Companies Associated With

      Company Designation Date of Appointment
      MEDICOBOX PHARMACY AND DIAGNOSTICS PRIVATE LIMITED Director 10-Jun-2023
      ANTIQUE IT VENTURES PRIVATE LIMITED Director 05-Oct-2006
      ACCORD MULTISPECIALITY CLINICS AND MEDI-INFRA PRIVATE LIMITED Additional Director 21-Apr-2023
      ATRIA STAR LOUNGE AND HOTELS PRIVATE LIMITED Director 25-Apr-2023
      ACCLAIM RESTAURANTS PRIVATE LIMITED Director 22-Apr-2023
      ACCORD WOMAN AND CHILD HOSPITAL AND RESEARCH CENTRE PRIVATE LIMITED Director 30-Nov-2021
      INTELLIBRIDGE CONSULTING PRIVATE LIMITED Director 22-Apr-2023
      ANTIQUE ENTERTAINMENT PRIVATE LIMITED Director 05-Oct-2006
      ATTIC RESTAURANTS PRIVATE LIMITED Director 21-Apr-2023
      ATREYA HEALTHCARE FOUNDATION Director 22-Apr-2023

      Past Companies Associated With

      Company Designation Date of Appointment Date of Cessation
      MEDICOBOX PHARMACY AND DIAGNOSTICS PRIVATE LIMITED Additional Director 10-Mar-2023 29-Sep-2023
      ATRIA STAR LOUNGE AND HOTELS PRIVATE LIMITED Additional Director 26-Dec-2022 29-Sep-2023
      ACCLAIM RESTAURANTS PRIVATE LIMITED Additional Director 26-Dec-2022 24-Sep-2023
      ACCORD WOMAN AND CHILD HOSPITAL AND RESEARCH CENTRE PRIVATE LIMITED Additional Director 27-Apr-2021 30-Nov-2021
      INTELLIBRIDGE CONSULTING PRIVATE LIMITED Additional Director 26-Mar-2007 31-May-2007
      INTELLIBRIDGE CONSULTING PRIVATE LIMITED Director 31-May-2007 05-May-2021
      ATTIC RESTAURANTS PRIVATE LIMITED Additional Director 26-Dec-2022 29-Sep-2023
      ATREYA HEALTHCARE FOUNDATION Additional Director 26-Dec-2022 29-Sep-2023

      “Assess financial performance of all companies under a director.”

      Explore Prime Research Explore for Sales